LATE-BREAKING ABSTRACT: Efficacy of Pirfenidone for Idiopathic Pulmonary Fibrosis (IPF): an Italian real life study
S. Harari, V. Giunta, C. Albera, C. Vancheri, V. Poletti, A. Pesci, F. Luppi, C. Saltini, C. Agostini, P. Rottoli, A. Sebastiani, A. Sanduzzi, A. Caminati, R. Della Porta, G. P. Bandelli, S. Puglisi, S. Tomassetti, A. Biffi, C. Stefania, A. Mari, F. Cinetto, F. Tirelli, G. Farinelli, M. Bocchino, M. Confalonieri (Milan, Turin, Catania, Forlì, Monza, Modena, Roma, Padua, Siena, Naples, Trieste, Italy)
Source: International Congress 2014 – IPF and surroundings
Session: IPF and surroundings
Session type: Oral Presentation
Number: 4626
Disease area: Interstitial lung diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Harari, V. Giunta, C. Albera, C. Vancheri, V. Poletti, A. Pesci, F. Luppi, C. Saltini, C. Agostini, P. Rottoli, A. Sebastiani, A. Sanduzzi, A. Caminati, R. Della Porta, G. P. Bandelli, S. Puglisi, S. Tomassetti, A. Biffi, C. Stefania, A. Mari, F. Cinetto, F. Tirelli, G. Farinelli, M. Bocchino, M. Confalonieri (Milan, Turin, Catania, Forlì, Monza, Modena, Roma, Padua, Siena, Naples, Trieste, Italy). LATE-BREAKING ABSTRACT: Efficacy of Pirfenidone for Idiopathic Pulmonary Fibrosis (IPF): an Italian real life study. Eur Respir J 2014; 44: Suppl. 58, 4626
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: